1. An antibody against pre-amyloid oligomers: a potential clinical tool or merely an intriguing observation?. (11th February 2020) Authors: Falk, Rodney H; Dorbala, Sharmila Journal: European heart journal Issue: Volume 41:Number 12(2020) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis. (11th March 2022) Authors: Giblin, Gerard T; Cuddy, Sarah A M; González-López, Esther; Sewell, Alanna; Murphy, Amanda; Dorbala, Sharmila; Falk, Rodney H Journal: European heart journal Issue: Volume 23:Number 8(2022) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. (2nd September 2021) Authors: Cohen, Oliver C; Ismael, Andreia; Pawarova, Babita; Manwani, Richa; Ravichandran, Sriram; Law, Steven; Foard, Darren; Petrie, Aviva; Ward, Sevda; Douglas, Brooke; Martinez-Naharro, Ana; Chacko, Liza; Quarta, Candida Cristina; Mahmood, Shameem; Sachchithanantham, Sajitha; Lachmann, Helen J; Hawkin... Journal: European heart journal Issue: Volume 43:Number 4(2022) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity. Issue 11 (15th October 2014) Authors: Guan, Jian; Mishra, Shikha; Qiu, Yiling; Shi, Jianru; Trudeau, Kyle; Las, Guy; Liesa, Marc; Shirihai, Orian S; Connors, Lawreen H; Seldin, David C; Falk, Rodney H; MacRae, Calum A; Liao, Ronglih Journal: EMBO molecular medicine Issue: Volume 6:Issue 11(2014:Nov.) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity. Issue 5 (May 2015) Authors: Guan, Jian; Mishra, Shikha; Qiu, Yiling; Shi, Jianru; Trudeau, Kyle; Las, Guy; Liesa, Marc; Shirihai, Orian S; Connors, Lawreen H; Seldin, David C; Falk, Rodney H; MacRae, Calum A; Liao, Ronglih Journal: EMBO molecular medicine Issue: Volume 7:Issue 5(2015:May) Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pulmonary venous isolation for atrial fibrillation in severe systolic heart failure: more questions than answers?. Issue 9 (30th January 2011) Authors: Falk, Rodney H Journal: Heart Issue: Volume 97:Issue 9(2011) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?. (18th January 2019) Authors: Falk, Rodney H Journal: European heart journal Issue: Volume 40:Number 12(2019) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis. (8th July 2020) Authors: Falk, Rodney H; Dorbala, Sharmila Journal: European heart journal Issue: Volume 41:Number 29(2020) Page Start: 2768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗